CIK: 1629383 - Address: C/O Avidity Biosciences, Inc., 10578 Science Center Drive, Suite 125, San Diego, CA 92121
14 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

9/23/24 21:01
9/23/24
RNAAvidity Biosciences, Inc.DEHealthDrugPharmaceutical PreparationsBoyce SarahCADOP,CEOS-1,44744.000-33-10297D
8/7/24 17:46
8/6/24
RNAAvidity Biosciences, Inc.DEHealthDrugPharmaceutical PreparationsBoyce SarahCADOP,CEOS.d-1,21443.350-28-12205D
7/11/24 16:07
7/9/24
RNAAvidity Biosciences, Inc.DEHealthDrugPharmaceutical PreparationsBoyce SarahCADOP,CEOS.d-1,11839.930-28-12205D
6/20/24 18:47
6/18/24
RNAAvidity Biosciences, Inc.DEHealthDrugPharmaceutical PreparationsBoyce SarahCADOP,CEOS-1,25539.130-32-14205D
6/14/24 18:58
6/12/24
RNAAvidity Biosciences, Inc.DEHealthDrugPharmaceutical PreparationsBoyce SarahCADOP,CEOS.dm-11,58838.630-300-73112D
6/5/24 17:46
6/4/24
RNAAvidity Biosciences, Inc.DEHealthDrugPharmaceutical PreparationsBoyce SarahCADOP,CEOS.d-76827.420-28-20112D
5/7/24 21:52
5/7/24
RNAAvidity Biosciences, Inc.DEHealthDrugPharmaceutical PreparationsBoyce SarahCADOP,CEOS.d-71525.540-28-20112D
4/3/24 18:16
4/2/24
RNAAvidity Biosciences, Inc.DEHealthDrugPharmaceutical PreparationsBoyce SarahCADOP,CEOS.d-73526.250-28-20112D
3/12/24 17:29
3/8/24
RNAAvidity Biosciences, Inc.DEHealthDrugPharmaceutical PreparationsBoyce SarahCADOP,CEOS.dm-2,43021.700-112-50112D
3/5/24 16:53
3/1/24
RNAAvidity Biosciences, Inc.DEHealthDrugPharmaceutical PreparationsBoyce SarahCADOP,CEOS.d-1,69120.130-84-43112D
1/23/24 15:13
1/22/24
RNAAvidity Biosciences, Inc.DEHealthDrugPharmaceutical PreparationsBoyce SarahCADOP,CEOS.d-5210.130-5-1044D
2/3/23 17:26
2/1/23
RNAAvidity Biosciences, Inc.DEHealthDrugPharmaceutical PreparationsBoyce SarahCADOP,CEOS.dm-1,21824.350-50-4853D
8/26/22 19:29
8/24/22
RNAAvidity Biosciences, Inc.DEHealthDrugPharmaceutical PreparationsBoyce SarahCADOP,CEOS.dm-1,14222.880-50-1000D
8/17/22 21:40
8/15/22
RNAAvidity Biosciences, Inc.DEHealthDrugPharmaceutical PreparationsBoyce SarahCADOP,CEOS.d-222.4700-1000D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact